This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudreau, C.
Right arrow Articles by Bekal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudreau, C.
Right arrow Articles by Bekal, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2008, p. 4475-4477, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.00767-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Comparison of Disk Diffusion and Agar Dilution Methods for Erythromycin, Ciprofloxacin, and Tetracycline Susceptibility Testing of Campylobacter coli and for Tetracycline Susceptibility Testing of Campylobacter jejuni subsp. jejuni{triangledown}

Christiane Gaudreau,1* Yves Girouard,2 Huguette Gilbert,1 Josée Gagnon,2 and Sadjia Bekal3

Centre hospitalier de l'Université de Montréal-Hôpital Saint-Luc, Montréal,1 Hôpital Sacré-Cœur, Montréal,2 Laboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada3

Received 12 June 2008/ Returned for modification 25 August 2008/ Accepted 28 September 2008

With disk diffusion, the following zone diameters are suggested to be resistant and susceptible breakpoints, respectively: for susceptibility testing of Campylobacter coli, no inhibition zone and 15 mm or more for erythromycin, and 20 mm or less and 25 mm or more for ciprofloxacin, in the absence or presence of an inhibition zone around the nalidixic acid disk; and for susceptibility testing of C. coli and Campylobacter jejuni, 20 mm or less and 26 mm or more for tetracycline.

* Corresponding author. Mailing address: Microbiologie médicale et Infectiologie, Hôpital Saint-Luc du CHUM, 1058 rue Saint Denis, Montréal, Québec, Canada H2X 3J4. Phone: (514) 890-8305, ext. 36209. Fax: (514) 412-7412. E-mail: christiane.gaudreau.chum{at}ssss.gouv.qc.ca

{triangledown} Published ahead of print on 6 October 2008.

Antimicrobial Agents and Chemotherapy, December 2008, p. 4475-4477, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.00767-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»